Cadrenal Therapeutics (CVKD) Q2 2025 Earnings

May 8Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-2.25
-1.93
-1.6
-1.28

Details

Expected EPS
-2.15
Actual EPS
-2.09
Surprise EPS
0.06
Surprise Percent
+2.79%

Description

⁨Cadrenal Therapeutics⁩ (⁦CVKD⁩) has reported earnings of ⁦-2.09⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts